Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2009-2-16
pubmed:abstractText
The noradrenergic and dopaminergic systems are targets for antidepressants and are stimulated by serotonergic antidepressant drugs. The COMT enzyme inactivates catecholamines, and the COMT Val(108/158)Met polymorphism (rs4680) influences the enzyme activity. Clinical studies on the effect of rs4680 on antidepressant response gave contrasting results.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0033-3158
pubmed:author
pubmed:issnType
Print
pubmed:volume
203
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
155-60
pubmed:meshHeading
pubmed-meshheading:18989660-Adult, pubmed-meshheading:18989660-Antidepressive Agents, Second-Generation, pubmed-meshheading:18989660-Catechol O-Methyltransferase, pubmed-meshheading:18989660-Catecholamines, pubmed-meshheading:18989660-Depressive Disorder, Major, pubmed-meshheading:18989660-Female, pubmed-meshheading:18989660-Heterozygote, pubmed-meshheading:18989660-Homozygote, pubmed-meshheading:18989660-Humans, pubmed-meshheading:18989660-Male, pubmed-meshheading:18989660-Middle Aged, pubmed-meshheading:18989660-Paroxetine, pubmed-meshheading:18989660-Polymorphism, Genetic, pubmed-meshheading:18989660-Psychiatric Status Rating Scales, pubmed-meshheading:18989660-Serotonin Uptake Inhibitors, pubmed-meshheading:18989660-Severity of Illness Index, pubmed-meshheading:18989660-Time Factors, pubmed-meshheading:18989660-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
The catechol-O-methyltransferase Val(108/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting.
pubmed:affiliation
Department of Clinical Neurosciences, Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy. benedetti.francesco@hsr.it
pubmed:publicationType
Journal Article